Comparison Chart Vanda Pharmaceuticals Inc.
Stocks
VNDA
US9216591084
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
14:36:24 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 3.965 USD | -0.88% |
|
-1.48% | -54.76% |
| 02:20am | Vanda Pharmaceuticals Inc., Q3 2026 Earnings Call, Oct 28, 2026 | |
| 10-28 | Vanda Pharmaceuticals Inc. Updates Earnings Guidance for 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VANDA PHARMACEUTICALS INC. | Bio Therapeutic Drugs | -0.50% | -1.48% | -54.76% | -26.25% | -76.69% | 242M |  | | |
- Stock Market
- Stocks
- VNDA Stock
- Charts Vanda Pharmaceuticals Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
